COVID-19-caused inflammation of the endothelium initially upregulates the activity of von Willebrand factor (vWf) and factor VIII, leading to inadequate balance by the otherwise often normal levels of its depolymerase (ADAMTS-13). This evidence concerns the gene VWF and COVID-19.